Study of rare pituitary and sellar region diseases
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study is collecting information from people with rare diseases of the pituitary gland or nearby areas. It aims to better understand these conditions and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rare condition in the sellar region of the brain (such as a specific type of pituitary tumor, craniopharyngioma, or Rathke's cleft cyst).
- You have a complete medical history that includes your symptoms, treatments, and follow-up results.
- Your medical records must include key imaging results (like MRI or CT scans) — no missing images.
- You do not have a separate, unrelated brain condition that could affect the study (like a severe head injury).
- Your diagnosis has stayed the same during follow-up (it was not changed or overturned).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies pituitary tumors that have spread into a nearby area called the cavernous sinus. It aims to learn more about these tumors by looking at donated tissue samples and health information to improve future care.
This research study investigates tumors and disorders of the pituitary gland (a small gland that controls many body hormones) and related areas of the brain. You may qualify if you have a pituitary tumor or disorder, or if you have a family history of these conditions.
This study tests a new type of absorbable (dissolvable) support plate used during minimally invasive surgery to remove tumors in the pituitary gland area. The plate helps support the surgical site as it heals. Researchers want to see if this new plate works safely and effectively compared to standard approaches.
This study is looking at children and teens with very rare tumors to learn more about these conditions and improve future care. It aims to gather information from patients treated at participating centers.
This study looks at whether blood and tissue markers, along with imaging features, can predict how aggressive a pituitary neuroendocrine tumor is and how it may affect long-term health. It aims to improve treatment decisions by better understanding these tumors.
This study looks at how doctors manage tumors that start in the nose/sinuses and spread to the skull base. It may help improve planning of care for people with this specific type and location of tumor.
Hear when a new Pituitary Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.